Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants.
Richard Matthew DoddsAntoneta GranicSian M RobinsonAvan A SayerPublished in: Journal of cachexia, sarcopenia and muscle (2019)
We have shown an overall prevalence of 5.3% of probable sarcopenia at ages 40-70 in UK Biobank. The risk of probable sarcopenia was higher in those with some categories of LTCs, suggesting that these groups may stand to benefit from assessment of sarcopenia, during mid-life as well as old age.